The ratio of 18F-FDG activity uptake between the right and left ventricle in patients with pulmonary hypertension correlates with the right ventricular function

Clinical Nuclear Medicine

Volumn 39, Issue 5, 2014, Pages 426-430

  Yang, Tao ^a   Wang, Lei ^a   Xiong, Chang Ming ^a   He, Jian Guo ^a   Zhang, Yan ^a   Gu, Qing ^a   Zhao, Zhi Hui ^a   Ni, Xin Hai ^a   Fang, Wei ^a   Liu, Zhi Hong ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

FDG PET; pulmonary hypertension; right ventricular function

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; DIET RESTRICTION; FEMALE; GLUCOSE TRANSPORT; HEART CATHETERIZATION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT ATRIUM PRESSURE; HEART RIGHT VENTRICLE EJECTION FRACTION; HUMAN; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MALE; ORAL GLUCOSE TOLERANCE TEST; POSITRON EMISSION TOMOGRAPHY; PULMONARY HYPERTENSION; CLINICAL TRIAL; DEMOGRAPHY; HEART RIGHT VENTRICLE FUNCTION; HEART VENTRICLE; HEMODYNAMICS; METABOLISM; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; SCINTISCANNING;

ADULT; DEMOGRAPHY; FASTING; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HEART VENTRICLES; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; MALE; MULTIVARIATE ANALYSIS; POSITRON-EMISSION TOMOGRAPHY; VENTRICULAR FUNCTION, RIGHT;

EID: 84898548235     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0000000000000422     Document Type: Article

References (20)

1. Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009;30:2493-2537.
2. van Wolferen SA, Marcus JT, Boonstra A, et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J. 2007;28:1250-1257.
3. Fang W, Zhao L, Xiong CM, et al. Comparison of 18F-FDG uptake by right ventricular myocardium in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease. Pulm Circ. 2012;2:365-372.
4. Oikawa M, Kagaya Y, Otani H, et al. Increased [18F]fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol. J Am Coll Cardiol. 2005;45:1849-1855.
5. Can MM, Kaymaz C, Tanboga IH, et al. Increased right ventricular glucose metabolism in patients with pulmonary arterial hypertension. Clin Nucl Med. 2011;36:743-748.
6. Hagan G, Southwood M, Treacy C, et al. (18)FDG PET imaging can quantify increased cellular metabolism in pulmonary arterial hypertension: a proof-ofprinciple study. Pulm Circ. 2011;1:448-455.
7. Basu S, Alavi A. Avid FDG uptake in the right ventricle coupled with enhanced intercostal muscle hypermetabolism in pneumoconiosis. Clin Nucl Med. 2007;32:407-408.
8. Brooks D, Solway S, Gibbons WJ. ATS statement on six-minute walk test. Am J Respir Crit Care Med. 2003;167:1287.
9. Mielniczuk LM, Birnie D, Ziadi MC, et al. Relation between right ventricular function and increased right ventricular [18F]fluorodeoxyglucose accumulation in patients with heart failure. Circ Cardiovasc Imaging. 2011;4:59-66.
10. Herrero P, Markham J, Myears D, et al. Measurement of myocardial blood flow with positron emission tomography: correction for count spillover and partial volume effects. Math Comput Model. 1988;11:807-812.
11. van der Vusse GJ, van Bilsen M, Glatz JF. Cardiac fatty acid uptake and transport in health and disease. Cardiovasc Res. 2000;45:279-293.
12. Bing RJ, Siegel A, Vitale A, et al. Metabolic studies on the human heart in vivo. I. Studies on carbohydrate metabolism of the human heart. Am J Med. 1953;15:284-296.
13. Benza R, Biederman R, Murali S, et al. Role of cardiac magnetic resonance imaging in the management of patients with pulmonary arterial hypertension. J Am Coll Cardiol. 2008;52:1683-1692.
14. Ding HJ, Shiau YC, Wang JJ, et al. The influences of blood glucose and duration of fasting on myocardial glucose uptake of [18F]fluoro-2-deoxy-D- glucose. Nucl Med Commun. 2002;23:961-965.
15. Sasaki H, Asanuma H, Fujita M, et al. Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase. Circulation. 2009; 119:2568-2577.
16. Liao R, Jain M, Cui L, et al. Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice. Circulation. 2002;106:2125-2131.
17. Liu X, Gai Y, Liu F, et al. Trimetazidine inhibits pressure overload-induced cardiac fibrosis through NADPH oxidase-ROS-CTGF pathway. Cardiovasc Res. 2010;88:150-158.
18. Zhang L, Lu Y, Jiang H, et al. Additional use of trimetazidine in patients with chronic heart failure: a meta-analysis. J Am Coll Cardiol. 2012;59:913-922.
19. Piao L, Fang YH, Cadete VJ, et al. The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle. J Mol Med (Berl). 2010;88:47-60.
20. Fang YH, Piao L, Hong Z, et al. Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle's cycle. J Mol Med (Berl). 2012;90:31-43.